# Desmopressin

## Minirin inj 4mcg/1mL (DDAVP)

| TAH Drug Code      | [IDDA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IDDA)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Central Diabetes Insipidus, Primary Nocturnal Enuresis, Renal Concentrating Capacity Test,Symptomatic treatment of nocturia in adults associated with nocturnal polyuria ie, nocturnal urine production exceeding bladder capacity. Hemophilia A and von Willebrand's Disease                                                                                                                                                                                                                                                                                  |
| Dosing             | Central diabetes insipidus: Adult: 1-4mcg(0.25-1mL) ; Children > 1 year 0.4-1mcg(0.1-0.25mL) ; Children < 1 year 0.2-0.4mcg(0.05-0.1mL), 1-2 times per day .Patients with mild to severe hemophilia or drug-induced platelet dysfunction: 0.3mcg/kg diluted with normal saline to 50-100mL, IV infusion for over 15-30 minutes, could repeat after 6-12 hours.                                                                                                                                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | - Patients allergic to desmopressin or any listed excipients - Patients with habitual or psychogenic polydipsia - Patients with a history of angina and/or known or suspected heart failure, as well as those requiring diuretics for other health conditions - Patients with known hyponatremia - Patients with Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) - Patients with Type IIB von Willebrand’s disease - Patients with moderate to severe renal impairment (creatinine clearance less than 50 mL/min) - Uncontrolled hypertension |
| Adverse Effects    | Nausea, abdominal pain, headache, nasal congestion/rhinitis, nose bleeds. Nasal spray May cause bronchospasm due to the presence of benzalkonium Cl. Dermatologic: Flushing Gastrointestinal: Nausea, Will respond to dosage decrease Neurologic: Fatigue (10% ), Headache (22.5% )                                                                                                                                                                                                                                                                            |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/desmopressin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## Minirin Melt 60mcg 凍晶口溶錠

| TAH Drug Code      | [OMIN6](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMIN6)                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Central diabetes insipidus, primary nocturnal enuresis (limited to patients aged 6 years and older), and adult nocturia due to nocturnal polyuria, where nighttime urine production exceeds bladder capacity.                                                                                                                                                                                                                                                                                                  |
| Dosing             | Central diabetes insipidus: Initial dose as 60mcg three times per day, followed by 60-120mcg three times per day as maintain dose.(Total daily dose:120mcg-720mcg.) Primary nocturia: 120mcg at bedtime, up to 240mcg if needed. Nocturia: 60mcg at bedtime, up to 120mcg after one week & subsequently 240mcg weekly dose escalations.To be administered sublingually.                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | - Patients with habitual or psychogenic polydipsia (resulting in urine output exceeding 40 mL/kg/24 hours); - Patients with a known or suspected history of heart failure and those requiring diuretics for other health conditions; - Patients with moderate to severe renal impairment (creatinine clearance <50 mL/min); - Patients with known hyponatremia; - Patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH); - Patients allergic to desmopressin or any other excipients. |
| Adverse Effects    | Nausea, abdominal pain, headache, nasal congestion/rhinitis, nose bleeds. Nasal spray May cause bronchospasm due to the presence of benzalkonium Cl. Dermatologic: Flushing Gastrointestinal: Nausea, Will respond to dosage decrease Neurologic: Fatigue (10% ), Headache (22.5% )                                                                                                                                                                                                                            |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/desmopressin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                    |

